Okuvision is one of the first forms of outpatient treatment for retinitis pigmentosa, whose effectiveness has been proven by clinical studies. About 20,000 people suffering from retinitis pigmentosa in Germany could profit from this.
It has been proven that the Okuvision therapy can delay the progress of the illness and thus preserve eyesight for a longer period. Its special feature: Okuvision transmits weak electrical impulses to the retina. This electronic stimulus to the retina helps to preserve eyesight for a longer period. Nevertheless, this Okuvision therapy for retinitis pigmentosa is hardly perceptible and as a rule causes no pain.

Please note: Our Product is not for sale in the US.